Patient-Centered Decision Support for Eosinophilic Esophagitis

StatusActive, Not Recruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Final enrollment: 55 participants (planned 40)
    • Primary completion date changed from estimate of Oct 6, 2026 to Sep 29, 2026
    • Study completion date: Dec 2026 to Jan 6, 2027
    • Site details revised
  2. Primary completion date: Sep 2026 to Oct 6, 2026
    • Eligibility criteria expanded, about 6 words
    • Secondary endpoints: details revised at 3 of 4 entries
  3. Primary completion date: Apr 2026 to Sep 2026
    • Study completion date: Jul 2026 to Dec 2026
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 2025 to Apr 16, 2025
    • Site details revised
    v3
  5. Primary completion date: Mar 2026 to Apr 2026
    • Study completion date: Jun 2026 to Jul 2026
    • Start date: Mar 2025 to Apr 2025
    • Site contact updated
    v2
  6. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study team is conducting this project to learn more about how patients with eosinophilic esophagitis (EoE) like to use and receive educational materials about treatment options and treatment decision making. This study will assess the efficacy of a decision support intervention to make decisions about treatment and disease management for patients with EoE and will assess the feasibility and acceptability of the intervention to inform future R01-level studies. The study team hypothesize that deploying the intervention will be feasible, and it will demonstrate high acceptability among EoE patients. Additionally, that patients that use the intervention (vs general education about EoE) will report greater treatment knowledge, increased readiness to choose a therapy, adherence to therapy, and follow-up.
Trial Details
NCT Number NCT06817213
Lead Sponsor University of Michigan
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)		 Eosinophilic Esophagitis
Related terms Eosinophilic Esophagitis
Enrollment 55 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov